<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>CLOMIPRAMINE HYDROCHLORIDE- clomipramine hydrochloride capsule </strong><br>Golden State Medical Supply, Inc.<br></p></div>
<h1>Clomipramine Hydrochloride Capsules USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_a3f5cc9c-5d12-4722-bca3-7b3be2db7343"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx only</span></p>
</div>
<div class="Warning">
<a name="BOX"></a><a name="section-2"></a><p></p>
<h1><span class="Emphasis">Suicidality and Antidepressant Drugs</span></h1>
<p class="First"><span class="Bold">Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive disorder</span> (MDD) and other psychiatric disorders. Anyone considering the use of clomipramine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span> and certain other psychiatric disorders are themselves associated with increases in the risk of <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Clomipramine hydrochloride is not approved for use in pediatric patients except for patients with <span class="product-label-link" type="condition" conceptid="440374" conceptname="Obsessive-compulsive disorder">obsessive compulsive disorder</span> (OCD) (</span><span class="Italics">see</span><span class="Bold"><a href="#cwasr"> WARNINGS, Clinical Worsening and <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span> Risk</a>;<a href="#info"> PRECAUTIONS, Information for Patients</a>;</span><span class="Italics"> and</span><span class="Bold"><a href="#_Ref"> PRECAUTIONS, Pediatric Use</a>).</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_b736b375-bb66-4a43-862a-dbd5229dbeb8"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Clomipramine hydrochloride capsules USP is an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Clomipramine hydrochloride is available as capsules of 25, 50 and 75 mg for oral administration.</p>
<p>Clomipramine hydrochloride USP is 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5<span class="Italics">H</span>-dibenz[<span class="Italics">b,f</span>] azepine monohydrochloride, and its structural formula is:</p>
<table width="100%">
<col width="62%">
<col width="38%">
<tbody class="Headless"><tr class="First Last">
<td class="Botrule Toprule" align="center" valign="top">
<a name="id30745188"></a><img alt="Clomipramine Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4c32971e-feb3-4388-9cd6-d1f99f258b0d&amp;name=clomipramine-01.jpg">
</td>
<td class="Botrule Toprule" valign="top"><p class="First">C<span class="Sub">19</span>H<span class="Sub">23</span>ClN<span class="Sub">2</span>∙HCl<br>Molecular weight: 351.31</p></td>
</tr></tbody>
</table>
<p>Clomipramine hydrochloride USP is a white to off-white crystalline powder. It is freely soluble in water, in methanol, and in methylene chloride, and insoluble in ethyl ether and in hexane.</p>
<p><span class="Italics">Inactive Ingredients</span>: black iron oxide (25 mg capsules only), colloidal silicon dioxide, D&amp;C yellow No. 10 (25 mg capsules only), FD&amp;C blue No. 2 (25 mg capsules only), FD&amp;C red No. 3 (25 mg capsules only), gelatin, magnesium stearate, pregelatinized maize starch, titanium dioxide, yellow iron oxide (50 mg capsules only).</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="CP"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="43681-6">
<a name="ID_0fea71d2-b165-4943-8769-f56142c5161a"></a><a name="section-3.1"></a><p></p>
<h2>Pharmacodynamics</h2>
<p class="First">Clomipramine (CMI) is presumed to influence obsessive and compulsive behaviors through its effects on serotonergic neuronal transmission. The actual neurochemical mechanism is unknown, but CMI's capacity to inhibit the reuptake of serotonin (5-HT) is thought to be important.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="ID_4b5f2661-d40f-4fad-a477-35e3eae5510c"></a><a name="section-3.2"></a><p></p>
<h2>Pharmacokinetics</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_fcf74348-d9df-45ef-8b2b-ef40a64e3858"></a><a name="section-3.2.1"></a><p></p>
<h3>Absorption/Bioavailability</h3>
<p class="First">CMI from clomipramine hydrochloride capsules is as bioavailable as CMI from a solution. The bioavailability of CMI from capsules is not significantly affected by food.</p>
<p>In a dose proportionality study involving multiple CMI doses, steady-state plasma concentrations (C<span class="Sub">ss</span>) and area-under-plasma-concentration-time curves (AUC) of CMI and CMI's major active metabolite, desmethylclomipramine (DMI), were not proportional to dose over the ranges evaluated, i.e., between 25 to 100 mg/day and between 25 to 150 mg/day, although C<span class="Sub">ss</span> and AUC are approximately linearly related to dose between 100 to 150 mg/day. The relationship between dose and CMI/DMI concentrations at higher daily doses has not been systematically assessed, but if there is significant dose dependency at doses above 150 mg/day, there is the potential for dramatically higher C<span class="Sub">ss</span> and AUC even for patients dosed within the recommended range. This may pose a potential risk to some patients (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span><span class="Italics"> and </span><span class="Bold"><a href="#DI">PRECAUTIONS, Drug Interactions</a></span>). After a single 50 mg oral dose, maximum plasma concentrations of CMI occur within 2 to 6 hours (mean, 4.7 hr) and range from 56 ng/mL to 154 ng/mL (mean, 92 ng/mL). After multiple daily doses of 150 mg of clomipramine hydrochloride, steady-state maximum plasma concentrations range from 94 ng/mL to 339 ng/mL (mean, 218 ng/mL) for CMI and from 134 ng/mL to 532 ng/mL (mean, 274 ng/mL) for DMI. Additional information from a rising dose study of doses up to 250 mg suggests that DMI may exhibit nonlinear pharmacokinetics over the usual dosing range. At a dose of Clomipramine Hydrochloride Capsules, 200 mg, subjects who had a single blood sample taken approximately 9 to 22 hours, (median 16 hours), after the dose had plasma concentrations of up to 605 ng/mL for CMI, 781 ng/mL for DMI, and 1386 ng/mL for both.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="distribution"></a><a name="section-3.2.2"></a><p></p>
<h3>Distribution</h3>
<p class="First">CMI distributes into cerebrospinal fluid (CSF) and brain and into breast milk. DMI also distributes into CSF, with a mean CSF/plasma ratio of 2.6. The protein binding of CMI is approximately 97%, principally to albumin, and is independent of CMI concentration. The interaction between CMI and other highly protein-bound drugs has not been fully evaluated, but may be important (<span class="Italics">see</span><span class="Bold"><a href="#DI"> PRECAUTIONS, Drug Interactions</a></span>).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_f7d745f1-59de-4ebd-a8e9-84d3c9e1cf75"></a><a name="section-3.2.3"></a><p></p>
<h3>Metabolism</h3>
<p class="First">CMI is extensively biotransformed to DMI and other metabolites and their glucuronide conjugates. DMI is pharmacologically active, but its effects on OCD behaviors are unknown. These metabolites are excreted in urine and feces, following biliary elimination. After a 25 mg radiolabeled dose of CMI in two subjects, 60% and 51%, respectively, of the dose were recovered in the urine and 32% and 24%, respectively, in feces. In the same study, the combined urinary recoveries of CMI and DMI were only about 0.8% to 1.3% of the dose administered. CMI does not induce drug-metabolizing enzymes, as measured by antipyrine half-life.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_3aee63be-a1ff-4116-bdc2-e02b8c1da834"></a><a name="section-3.2.4"></a><p></p>
<h3>Elimination</h3>
<p class="First">Evidence that the C<span class="Sub">ss</span> and AUC for CMI and DMI may increase disproportionately with increasing oral doses suggests that the metabolism of CMI and DMI may be capacity limited. This fact must be considered in assessing the estimates of the pharmacokinetic parameters presented below, as these were obtained in individuals exposed to doses of 150 mg. If the pharmacokinetics of CMI and DMI are nonlinear at doses above 150 mg, their elimination half-lives may be considerably lengthened at doses near the upper end of the recommended dosing range (i.e., 200 mg/day to 250 mg/day). Consequently, CMI and DMI may accumulate, and this accumulation may increase the incidence of any dose- or plasma-concentration-dependent adverse reactions, in particular <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span>).</p>
<p>After a 150 mg dose, the half-life of CMI ranges from 19 hours to 37 hours (mean, 32 hr) and that of DMI ranges from 54 hours to 77 hours (mean, 69 hr). Steady-state levels after multiple dosing are typically reached within 7 to 14 days for CMI. Plasma concentrations of the metabolite exceed the parent drug on multiple dosing. After multiple dosing with 150 mg/day, the accumulation factor for CMI is approximately 2.5 and for DMI is 4.6. Importantly, it may take two weeks or longer to achieve this extent of accumulation at constant dosing because of the relatively long elimination half-lives of CMI and DMI (<span class="Italics">see </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a></span>). The effects of hepatic and <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> on the disposition of clomipramine hydrochloride have not been determined.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="interactions"></a><a name="section-3.2.5"></a><p></p>
<h3>Interactions</h3>
<p class="First">Co-administration of haloperidol with CMI increases plasma concentrations of CMI. Co-administration of CMI with phenobarbital increases plasma concentrations of phenobarbital (<span class="Italics">see </span><span class="Bold"><a href="#DI">PRECAUTIONS, Drug Interactions</a></span>). Younger subjects (18 to 40 years of age) tolerated CMI better and had significantly lower steady-state plasma concentrations, compared with subjects over 65 years of age. Children under 15 years of age had significantly lower plasma concentration/dose ratios, compared with adults. Plasma concentrations of CMI were significantly lower in smokers than in <span class="product-label-link" type="condition" conceptid="4222303" conceptname="Non-smoker">nonsmokers</span>.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="IU"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Clomipramine hydrochloride capsules USP are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the DSM-III-R (circa 1989) diagnosis of OCD.</p>
<p>Obsessions are recurrent, persistent ideas, thoughts, images, or impulses that are ego-dystonic. Compulsions are repetitive, purposeful, and intentional behaviors performed in response to an obsession or in a stereotyped fashion, and are recognized by the person as excessive or unreasonable.</p>
<p>The effectiveness of clomipramine for the treatment of OCD was demonstrated in multicenter, placebo-controlled, parallel-group studies, including two 10-week studies in adults and one 8-week study in children and adolescents 10 to 17 years of age. Patients in all studies had moderate-to-severe OCD (DSM-III), with mean baseline ratings on the Yale-Brown Obsessive Compulsive Scale (YBOCS) ranging from 26 to 28 and a mean baseline rating of 10 on the NIMH Clinical Global Obsessive Compulsive Scale (NIMH-OC). Patients taking CMI experienced a mean reduction of approximately 10 on the YBOCS, representing an average improvement on this scale of 35% to 42% among adults and 37% among children and adolescents. CMI-treated patients experienced a 3.5 unit decrement on the NIMH-OC. Patients on placebo showed no important clinical response on either scale. The maximum dose was 250 mg/day for most adults and 3 mg/kg/day (up to 200 mg) for all children and adolescents.</p>
<p>The effectiveness of clomipramine for long-term use (i.e., for more than 10 weeks) has not been systematically evaluated in placebo-controlled trials. The physician who elects to use clomipramine for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient (<span class="Italics">see</span><span class="Bold"><a href="#DAA"> DOSAGE AND ADMINISTRATION</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="contraindications"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Clomipramine hydrochloride capsules USP are contraindicated in patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to clomipramine or other tricyclic antidepressants.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_2f8fcb9a-a4ed-43b1-b983-7dd72c35f4c3"></a><a name="section-5.1"></a><p></p>
<h2>Monoamine Oxidase Inhibitors (MAOIs)</h2>
<p class="First">The use of MAOIs intended to treat psychiatric disorders with clomipramine or within 14 days of stopping treatment with clomipramine is contraindicated because of an increased risk of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span>. The use of clomipramine within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span><span class="Italics"> and </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a></span>).</p>
<p>Starting clomipramine in a patient who is being treated with linezolid or intravenous methylene blue is also contraindicated because of an increased risk of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span> (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span><span class="Italics"> and </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a></span>).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_0d77e904-00d3-43ac-8bfd-196247377829"></a><a name="section-5.2"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">Myocardial Infarction</span></h2>
<p class="First">Clomipramine is contraindicated during the acute recovery period after a <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">myocardial infarction</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="warnings"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="cwasr"></a><a name="section-6.1"></a><p></p>
<h2>Clinical Worsening and <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span> Risk</h2>
<p class="First">Patients with major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive disorder</span> (MDD), both adult and pediatric, may experience worsening of their <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and/or the emergence of <span class="product-label-link" type="condition" conceptid="4092095" conceptname="Planning suicide">suicidal ideation</span> and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span> is a known risk of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>. There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and the emergence of suicidality in certain patients during the early phases of treatment. Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive disorder</span> (MDD) and other psychiatric disorders. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.</p>
<p>The pooled analyses of placebo-controlled trials in children and adolescents with MDD, <span class="product-label-link" type="condition" conceptid="440374" conceptname="Obsessive-compulsive disorder">obsessive compulsive disorder</span> (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients. The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients. There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied. There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD. The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications. These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in<span class="Bold"> Table 1</span>.</p>
<a name="_Reftable1"></a><table width="75%">
<caption><span>Table 1</span></caption>
<col width="12%">
<col width="64%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="left" valign="top"><span class="Bold">Age Range</span></th>
<th class="Botrule Rrule Toprule" align="left" valign="top"><span class="Bold">Drug-Placebo Difference in Number of Cases of Suicidality per 1000 Patients Treated</span></th>
</tr>
<tr class="Last"><th class="Botrule Lrule Rrule" align="left" colspan="2" valign="top"><span class="Bold">Increases Compared to Placebo</span></th></tr>
</thead>
<tbody>
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">&lt;18</p></td>
<td class="Botrule Rrule Toprule" valign="top"><p class="First">14 additional cases</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">18-24</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5 additional cases</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="2" valign="top"><p class="First"><span class="Bold">Decreases Compared to Placebo</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">25-64</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1 fewer case</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" valign="top"><p class="First">≥65</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6 fewer cases</p></td>
</tr>
</tbody>
</table>
<p>No <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicides</span> occurred in any of the pediatric trials. There were <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicides</span> in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>.</p>
<p>It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months. However, there is substantial evidence from placebo-controlled maintenance trials in adults with <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> that the use of antidepressants can delay the recurrence of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>.</p>
<p><span class="Bold">All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.</span></p>
<p>The following symptoms, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4021498" conceptname="Panic attack">panic attacks</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4195585" conceptname="Hostile behavior">hostility</span>, <span class="product-label-link" type="condition" conceptid="4021344" conceptname="Abusive behavior">aggressiveness</span>, impulsivity, <span class="product-label-link" type="condition" conceptid="4108925" conceptname="Akathisia">akathisia</span> (<span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">psychomotor restlessness</span>), <span class="product-label-link" type="condition" conceptid="4333678" conceptname="Hypomania">hypomania</span>, and <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">mania</span>, have been reported in adult and pediatric patients being treated with antidepressants for major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive disorder</span> as well as for other indications, both psychiatric and nonpsychiatric. Although a causal link between the emergence of such symptoms and either the worsening of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality.</p>
<p>Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms.</p>
<p><span class="Bold">Families and caregivers of patients being treated with antidepressants for major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive disorder</span> or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers. Such monitoring should include daily observation by families and caregivers. </span>Prescriptions for clomipramine hydrochloride should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_c369ae64-7ebc-4d16-8b39-9eca9e877955"></a><a name="section-6.2"></a><p></p>
<h2>Screening Patients for Bipolar Disorder</h2>
<p class="First">A major <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive episode</span> may be the initial presentation of bipolar disorder. It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/<span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">manic episode</span> in patients at risk for bipolar disorder. Whether any of the symptoms described above represent such a conversion is unknown. However, prior to initiating treatment with an antidepressant, patients with <span class="product-label-link" type="condition" conceptid="4191716" conceptname="Symptoms of depression">depressive symptoms</span> should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>, bipolar disorder, and <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>. It should be noted that clomipramine hydrochloride is not approved for use in treating <span class="product-label-link" type="condition" conceptid="436665" conceptname="Bipolar disorder">bipolar depression</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_7eb4ac97-233c-447b-8301-f7a9adbbb9f5"></a><a name="section-6.3"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">Serotonin Syndrome</span></h2>
<p class="First">The development of a potentially life-threatening <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span> has been reported with SNRIs and SSRIs, including clomipramine, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).</p>
<p><span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">Serotonin syndrome</span> symptoms may include <span class="product-label-link" type="condition" conceptid="436222" conceptname="Altered mental status">mental status changes</span> (e.g., <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span>, and <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>), <span class="product-label-link" type="condition" conceptid="434633" conceptname="Disorder of autonomic nervous system">autonomic instability</span> (e.g., <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="4354255" conceptname="Labile blood pressure">labile blood pressure</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span>), neuromuscular changes (e.g., <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4050941" conceptname="Muscle rigidity">rigidity</span>, <span class="product-label-link" type="condition" conceptid="441553" conceptname="Myoclonus">myoclonus</span>, <span class="product-label-link" type="condition" conceptid="4313132" conceptname="Hyperreflexia">hyperreflexia</span>, <span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">incoordination</span>), <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, and/or <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">gastrointestinal symptoms</span> (e.g., <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>). Patients should be monitored for the emergence of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span>.</p>
<p>The concomitant use of clomipramine with MAOIs intended to treat psychiatric disorders is contraindicated. Clomipramine should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue. All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg. No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses. There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking clomipramine. Clomipramine should be discontinued before initiating treatment with the MAOI (<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a></span><span class="Italics"> and </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a></span>). If concomitant use of clomipramine with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span>, particularly during treatment initiation and dose increases.</p>
<p>Treatment with clomipramine and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_52cb4966-90e9-4645-9f61-5e09ba606dcd"></a><a name="section-6.4"></a><p></p>
<h2>Angle-Closure <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">Glaucoma</span></h2>
<p class="First">The pupillary dilation that occurs following use of many antidepressant drugs including clomipramine may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_8afbd441-860d-4da8-a908-37b2446685a6"></a><a name="section-6.5"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span></h2>
<p class="First">During premarket evaluation, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> was identified as the most significant risk of clomipramine use. </p>
<p>The observed cumulative incidence of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> among patients exposed to clomipramine at doses up to 300 mg/day was 0.64% at 90 days, 1.12% at 180 days, and 1.45% at 365 days. The cumulative rates correct the crude rate of 0.7%, (25 of 3519 patients) for the variable duration of exposure in clinical trials.</p>
<p>Although dose appears to be a predictor of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>, there is a confounding of dose and duration of exposure, making it difficult to assess independently the effect of either factor alone. The ability to predict the occurrence of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> in subjects exposed to doses of CMI greater than 250 mg is limited, given that the plasma concentration of CMI may be dose-dependent and may vary among subjects given the same dose. Nevertheless, prescribers are advised to limit the daily dose to a maximum of 250 mg in adults and 3 mg/kg (or 200 mg) in children and adolescents (<span class="Italics">see </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a></span>).</p>
<p>Caution should be used in administering clomipramine to patients with a history of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> or other predisposing factors, e.g., <span class="product-label-link" type="condition" conceptid="4080670" conceptname="Brain damage">brain damage</span> of varying etiology, <span class="product-label-link" type="condition" conceptid="4218106" conceptname="Alcoholism">alcoholism</span>, and concomitant use with other drugs that lower the <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> threshold.</p>
<p>Rare reports of fatalities in association with <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> have been reported by foreign postmarketing surveillance, but not in U.S. clinical trials. In some of these cases, clomipramine had been administered with other epileptogenic agents; in others, the patients involved had possibly predisposing medical conditions. Thus a causal association between clomipramine treatment and these fatalities has not been established.</p>
<p>Physicians should discuss with patients the risk of taking clomipramine while engaging in activities in which sudden <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">loss of consciousness</span> could result in serious injury to the patient or others, e.g., the operation of complex machinery, driving, swimming, climbing.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_abce7328-cd37-4370-b97a-caa81a4ca20e"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_21032676-8bd6-4cea-9268-f7c3e7186a5f"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_56797848-7568-4981-bcf0-41746a3aea73"></a><a name="section-7.1.1"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span></h3>
<p class="First">Since <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> is a commonly associated feature of OCD, the risk of <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span> must be considered. Prescriptions for clomipramine hydrochloride should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_129e8cc9-2f63-4f1c-b17f-86ba7c13088c"></a><a name="section-7.1.2"></a><p></p>
<h3>Cardiovascular Effects</h3>
<p class="First">Modest orthostatic decreases in blood pressure and modest <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span> were each seen in approximately 20% of patients taking clomipramine hydrochloride in clinical trials; but patients were frequently asymptomatic. Among approximately 1400 patients treated with CMI in the premarketing experience who had ECGs, 1.5% developed abnormalities during treatment, compared with 3.1% of patients receiving active control drugs and 0.7% of patients receiving placebo. The most common ECG changes were PVCs, ST-T wave changes, and intraventricular conduction abnormalities. These changes were rarely associated with significant clinical symptoms. Nevertheless, caution is necessary in treating patients with known cardiovascular disease, and gradual dose titration is recommended.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_02ad04eb-c929-4cf8-9bd7-12f98c28a6db"></a><a name="section-7.1.3"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">Psychosis</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">Confusion</span>, And Other Neuropsychiatric Phenomena</h3>
<p class="First">Patients treated with clomipramine have been reported to show a variety of neuropsychiatric signs and symptoms including <span class="product-label-link" type="condition" conceptid="444401" conceptname="Delusions">delusions</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychotic episodes</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, and <span class="product-label-link" type="condition" conceptid="432590" conceptname="Delusional disorder">paranoia</span>. Because of the uncontrolled nature of many of the studies, it is impossible to provide a precise estimate of the extent of risk imposed by treatment with clomipramine. As with tricyclic antidepressants to which it is closely related, clomipramine may precipitate an acute <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychotic episode</span> in patients with unrecognized <span class="product-label-link" type="condition" conceptid="435783" conceptname="Schizophrenia">schizophrenia</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_a3fc2d9f-ba57-42cc-9548-70730c356702"></a><a name="section-7.1.4"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">Mania</span>/<span class="product-label-link" type="condition" conceptid="4333678" conceptname="Hypomania">Hypomania</span></h3>
<p class="First">During premarketing testing of clomipramine in patients with <span class="product-label-link" type="condition" conceptid="444100" conceptname="Mood disorder">affective disorder</span>, <span class="product-label-link" type="condition" conceptid="4333678" conceptname="Hypomania">hypomania</span> or <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">mania</span> was precipitated in several patients. Activation of <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">mania</span> or <span class="product-label-link" type="condition" conceptid="4333678" conceptname="Hypomania">hypomania</span> has also been reported in a small proportion of patients with <span class="product-label-link" type="condition" conceptid="444100" conceptname="Mood disorder">affective disorder</span> treated with marketed tricyclic antidepressants, which are closely related to clomipramine.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_6a3cc61a-3e32-48ee-ab96-11fccce9d005"></a><a name="section-7.1.5"></a><p></p>
<h3>Hepatic Changes</h3>
<p class="First">During premarketing testing, clomipramine was occasionally associated with elevations in <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span> and SGPT (pooled incidence of approximately 1% and 3%, respectively) of potential clinical importance (i.e., values greater than 3 times the upper limit of normal). In the vast majority of instances, these enzyme increases were not associated with other clinical findings suggestive of hepatic injury; moreover, none were jaundiced. Rare reports of more severe <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span>, some fatal, have been recorded in foreign postmarketing experience. Caution is indicated in treating patients with known liver disease, and periodic monitoring of hepatic enzyme levels is recommended in such patients.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_d3a19f89-fa8f-452f-acba-432245514634"></a><a name="section-7.1.6"></a><p></p>
<h3>Hematologic Changes</h3>
<p class="First">Although no instances of severe hematologic toxicity were seen in the premarketing experience with clomipramine, there have been postmarketing reports of <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>, and <span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span> in association with clomipramine hydrochloride capsules USP use. As is the case with tricyclic antidepressants to which clomipramine is closely related, leukocyte and differential blood counts should be obtained in patients who develop <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span> during treatment with clomipramine.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_0999a4f1-d997-4f8b-8025-6f6517679e4a"></a><a name="section-7.1.7"></a><p></p>
<h3>Central Nervous System</h3>
<p class="First">More than 30 cases of <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span> have been recorded by nondomestic post-marketing surveillance systems. Most cases occurred when clomipramine was used in combination with other drugs. When clomipramine and a neuroleptic were used concomitantly, the cases were sometimes considered to be examples of a <span class="product-label-link" type="condition" conceptid="379802" conceptname="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="sexual_D"></a><a name="section-7.1.8"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="4237140" conceptname="Abnormal sexual function">Sexual Dysfunction</span></h3>
<p class="First">The rate of <span class="product-label-link" type="condition" conceptid="4237140" conceptname="Abnormal sexual function">sexual dysfunction</span> in male patients with OCD who were treated with clomipramine in the premarketing experience was markedly increased compared with placebo controls (i.e., 42% experienced ejaculatory failure and 20% experienced <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>, compared with 2.0% and 2.6%, respectively, in the placebo group). Approximately 85% of males with <span class="product-label-link" type="condition" conceptid="4237140" conceptname="Abnormal sexual function">sexual dysfunction</span> chose to continue treatment.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_09056f2e-603f-43e3-a6c5-82ab9f50b8f6"></a><a name="section-7.1.9"></a><p></p>
<h3>Weight Changes</h3>
<p class="First">In controlled studies of OCD, <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span> was reported in 18% of patients receiving clomipramine, compared with 1% of patients receiving placebo. In these studies, 28% of patients receiving clomipramine had a <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span> of at least 7% of their initial body weight, compared with 4% of patients receiving placebo. Several patients had <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gains</span> in excess of 25% of their initial body weight. Conversely, 5% of patients receiving clomipramine and 1% receiving placebo had <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight losses</span> of at least 7% of their initial body weight.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_917e2b87-ddd0-4b15-acc0-aca6d324db30"></a><a name="section-7.1.10"></a><p></p>
<h3>Electroconvulsive Therapy</h3>
<p class="First">As with closely related tricyclic antidepressants, concurrent administration of clomipramine with electroconvulsive therapy may increase the risks; such treatment should be limited to those patients for whom it is essential, since there is limited clinical experience.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_65ac74f9-82d7-471d-a457-4adf35164526"></a><a name="section-7.1.11"></a><p></p>
<h3>Surgery</h3>
<p class="First">Prior to elective surgery with general anesthetics, therapy with clomipramine should be discontinued for as long as is clinically feasible, and the anesthetist should be advised.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_4f60c42b-49ac-490a-91f1-487a0082ede1"></a><a name="section-7.1.12"></a><p></p>
<h3>Use in Concomitant Illness</h3>
<p class="First">As with closely related tricyclic antidepressants, clomipramine should be used with caution in the following:</p>
<dl>
<dt>1.</dt>
<dd>Hyperthyroid patients or patients receiving thyroid medication, because of the possibility of cardiac toxicity;</dd>
<dt>2.</dt>
<dd>Patients with <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, a history of narrow-angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, or <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, because of the anticholinergic properties of the drug;</dd>
<dt>3.</dt>
<dd>Patients with tumors of the adrenal medulla (e.g., <span class="product-label-link" type="condition" conceptid="4118993" conceptname="Pheochromocytoma">pheochromocytoma</span>, <span class="product-label-link" type="condition" conceptid="4333766" conceptname="Neuroblastoma">neuroblastoma</span>) in whom the drug may provoke hypertensive crises;</dd>
<dt>4.</dt>
<dd>Patients with significantly <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="WS"></a><a name="section-7.1.13"></a><p></p>
<h3>Withdrawal Symptoms</h3>
<p class="First">A variety of withdrawal symptoms have been reported in association with abrupt discontinuation of clomipramine, including <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>, <span class="product-label-link" type="condition" conceptid="435524" conceptname="Sleep disorder">sleep disturbance</span>, <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span>, and <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>. In addition, such patients may experience a worsening of psychiatric status. While the withdrawal effects of clomipramine have not been systematically evaluated in controlled trials, they are well known with closely related tricyclic antidepressants, and it is recommended that the dosage be tapered gradually and the patient monitored carefully during discontinuation (<span class="Italics">see </span><span class="Bold"><a href="#DAAD">DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></a></span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="info"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with clomipramine hydrochloride and should counsel them in its appropriate use. A patient Medication Guide about "Antidepressant Medicines, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span> and other Serious Mental Illness, and Suicidal Thoughts or Actions" is available for clomipramine hydrochloride. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have. The complete text of the Medication Guide is reprinted at the end of this document.</p>
<p>Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking clomipramine hydrochloride.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_8936a23a-50c7-4d7b-a553-edaa354dac74"></a><a name="section-7.2.1"></a><p></p>
<h3>Clinical Worsening and <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span> Risk</h3>
<p class="First">Patients, their families, and their caregivers should be encouraged to be alert to the emergence of <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4021498" conceptname="Panic attack">panic attacks</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4195585" conceptname="Hostile behavior">hostility</span>, <span class="product-label-link" type="condition" conceptid="4021344" conceptname="Abusive behavior">aggressiveness</span>, impulsivity, <span class="product-label-link" type="condition" conceptid="4108925" conceptname="Akathisia">akathisia</span> (<span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">psychomotor restlessness</span>), <span class="product-label-link" type="condition" conceptid="4333678" conceptname="Hypomania">hypomania</span>, <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">mania</span>, other unusual changes in behavior, worsening of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, and <span class="product-label-link" type="condition" conceptid="4092095" conceptname="Planning suicide">suicidal ideation</span>, especially early during antidepressant treatment and when the dose is adjusted up or down. Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt. Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms. Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication. Physicians are advised to discuss the following issues with patients for whom they prescribe clomipramine hydrochloride capsules:</p>
<dl>
<dt>1.</dt>
<dd>The risk of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span>);</dd>
<dt>2.</dt>
<dd>The relatively high incidence of <span class="product-label-link" type="condition" conceptid="4237140" conceptname="Abnormal sexual function">sexual dysfunction</span> among males (<span class="Italics">see </span><span class="Bold"><a href="#sexual_D"><span class="product-label-link" type="condition" conceptid="4237140" conceptname="Abnormal sexual function">Sexual Dysfunction</span></a></span>);</dd>
<dt>3.</dt>
<dd>Since clomipramine may impair the mental and/or physical abilities required for the performance of complex tasks, and since clomipramine is associated with a risk of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, patients should be cautioned about the performance of complex and hazardous tasks (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span>);</dd>
<dt>4.</dt>
<dd>Patients should be cautioned about using alcohol, barbiturates, or other CNS depressants concurrently, since clomipramine may exaggerate their response to these drugs;</dd>
<dt>5.</dt>
<dd>Patients should notify their physician if they become pregnant or intend to become pregnant during therapy;</dd>
<dt>6.</dt>
<dd>Patients should notify their physician if they are breast-feeding.</dd>
</dl>
<p>Patients should be advised that taking clomipramine can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle-closure <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>. Preexisting <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> is almost always open-angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> because angle-closure <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, when diagnosed, can be treated definitively with iridectomy. Open-angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> is not a risk factor for angle-closure <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>. Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> procedure (e.g., iridectomy), if they are susceptible.</p>
</div>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="DI"></a><a name="section-7.3"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">The risks of using clomipramine in combination with other drugs have not been systematically evaluated. Given the primary CNS effects of clomipramine, caution is advised in using it concomitantly with other CNS-active drugs (<span class="Italics">see </span><span class="Bold"><a href="#info">Information for Patients</a></span>). Clomipramine should<span class="Italics"> not </span>be used with MAO inhibitors (<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a></span>). Close supervision and careful adjustment of dosage are required when clomipramine is administered with anticholinergic or sympathomimetic drugs.</p>
<p>Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.</p>
<p>The plasma concentration of CMI has been reported to be increased by the concomitant administration of haloperidol; plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well. Administration of CMI has been reported to increase the plasma levels of phenobarbital, if given concomitantly (<span class="Italics">see </span><span class="Bold"><a href="#interactions">CLINICAL PHARMACOLOGY, Interactions</a></span>).</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_e9c4476d-36c7-4e8f-a3c9-670e59bbe2f0"></a><a name="section-7.3.1"></a><p></p>
<h3>Drugs Metabolized by P450 2D6</h3>
<p class="First">The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so-called "poor metabolizers"); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available. Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses. Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA). In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers. An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy. The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide). While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition. Fluvoxamine has also been shown to inhibit P450 1A2, an isoform also involved in TCA metabolism. The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved. Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other. Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary). Concomitant use of agents in tricyclic antidepressant class (which includes clomipramine) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug. Furthermore, whenever one of these drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant agent may be required. It is desirable to monitor TCA plasma levels whenever an agent of the tricyclic antidepressant class including clomipramine is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).</p>
<p>Because clomipramine is highly bound to serum protein, the administration of clomipramine to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects. Conversely, adverse effects may result from displacement of protein-bound clomipramine by other highly bound drugs (<span class="Italics">see </span><span class="Bold"><a href="#distribution">CLINICAL PHARMACOLOGY, Distribution</a></span>).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_138594d6-151d-4c9a-8322-61218b4e83d1"></a><a name="section-7.3.2"></a><p></p>
<h3>Monoamine Oxidase Inhibitors (MAOIs)</h3>
<p class="First">(<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a>,<a href="#warnings"> WARNINGS</a>,</span><span class="Italics"> and </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a>.</span>)</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_090710f7-a4fd-4f5f-99f2-74dfc7d034c9"></a><a name="section-7.3.3"></a><p></p>
<h3>Serotonergic Drugs</h3>
<p class="First">(<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a>,<a href="#warnings"> WARNINGS</a>,</span><span class="Italics"> and </span><span class="Bold"><a href="#DAA">DOSAGE AND ADMINISTRATION</a>.</span>)</p>
</div>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_7fb7d499-cb06-4e2a-85db-c9c626ff00ce"></a><a name="section-7.4"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No evidence of carcinogenicity was found in two 2-year bioassays in rats at doses up to 100 mg/kg, which is 24 and 4 times the maximum recommended human daily dose (MRHD) on a mg/kg and mg/m<span class="Sup">2</span> basis, respectively, or in a 2-year bioassay in mice at doses up to 80 mg/kg, which is 20 and 1.5 times the MRHD on a mg/kg and mg/m<span class="Sup">2</span> basis respectively.</p>
<p>In reproduction studies, no effects on fertility were found in rats given up to 24 mg/kg, which is 6 times, and approximately equal to, the MRHD on a mg/kg and mg/m<span class="Sup">2</span> basis, respectively.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_93ab0e88-8163-4ce3-acb5-41c699883f3e"></a><a name="section-7.5"></a><p></p>
<h2>Pregnancy Category C</h2>
<p class="First">No teratogenic effects were observed in studies performed in rats and mice at doses up to 100 mg/kg, which is 24 times the maximum recommended human daily dose (MRHD) on a mg/kg basis and 4 times (rats) and 2 times (mice) the MRHD on a mg/m<span class="Sup">2</span> basis. Slight nonspecific embryo/fetotoxic effects were seen in the offspring of treated rats given 50 and 100 mg/kg and of treated mice given 100 mg/kg.</p>
<p>There are no adequate or well-controlled studies in pregnant women. Withdrawal symptoms, including <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">jitteriness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, and <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, have been reported in neonates whose mothers had taken clomipramine until delivery. Clomipramine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_6bfe931c-dc42-45c8-bd30-c01b89530dc6"></a><a name="section-7.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Clomipramine hydrochloride has been found in human milk. Because of the potential for adverse reactions, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="P_Ped"></a><a name="section-7.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in the pediatric population other than pediatric patients with OCD have not been established (<span class="Italics">see </span><span class="Bold"><a href="#BOX">BOX WARNING</a></span><span class="Italics"> and </span><span class="Bold"><a href="#cwasr">WARNINGS, Clinical Worsening and <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span> Risk</a></span>). Anyone considering the use of clomipramine in a child or adolescent must balance the potential risks with the clinical need.</p>
<p>In a controlled clinical trial in children and adolescents (10 to 17 years of age), 46 outpatients received clomipramine for up to 8 weeks. In addition, 150 adolescent patients have received clomipramine in open-label protocols for periods of several months to several years. Of the 196 adolescents studied, 50 were 13 years of age or less and 146 were 14 to 17 years of age. The adverse reaction profile in this age group (<span class="Italics">see </span><span class="Bold"><a href="#AR">ADVERSE REACTIONS</a></span>) is similar to that observed in adults.</p>
<p>The risks, if any, that may be associated with clomipramine's extended use in children and adolescents with OCD have not been systemically assessed. The evidence supporting the conclusion that clomipramine is safe for use in children and adolescents is derived from relatively short term clinical studies and from extrapolation of experience gained with adult patients. In particular, there are no studies that directly evaluate the effects of long term clomipramine use on the growth, development, and maturation of children and adolescents. Although there is no evidence to suggest that clomipramine adversely affects growth, development or maturation, the absence of such findings is not adequate to rule out a potential for such effects in chronic use.</p>
<p>The safety and effectiveness in pediatric patients below the age of 10 have not been established. Therefore, specific recommendations cannot be made for the use of clomipramine in pediatric patients under the age of 10.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="ID_a915bc42-4335-4fb3-95f8-70f93f7c5f1c"></a><a name="section-7.8"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of clomipramine did not include sufficient numbers of subjects age 65 and over to determine whether they respond differently from younger subjects; 152 patients at least 60 years of age participating in various U.S. clinical trials received clomipramine for periods of several months to several years. No unusual age-related adverse events were identified in this population. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="AR"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_7bde872a-9a4e-44c0-b01f-f1da9c9fa109"></a><a name="section-8.1"></a><p></p>
<h2>Commonly Observed</h2>
<p class="First">The most commonly observed adverse events associated with the use of clomipramine and not seen at an equivalent incidence among placebo-treated patients were gastrointestinal complaints, including <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">dyspepsia</span>, and <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>; nervous system complaints, including <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, and <span class="product-label-link" type="condition" conceptid="441553" conceptname="Myoclonus">myoclonus</span>; genitourinary complaints, including changed libido, ejaculatory failure, <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>, and micturition disorder; and other miscellaneous complaints, including <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="4217027" conceptname="Increased appetite">increased appetite</span>, <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span>, and visual changes.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_6ed46478-8c0a-4019-972b-14953cf5dd2d"></a><a name="section-8.2"></a><p></p>
<h2>Leading to Discontinuation of Treatment</h2>
<p class="First">Approximately 20% of 3616 patients who received clomipramine in U.S. premarketing clinical trials discontinued treatment because of an adverse event. Approximately one-half of the patients who discontinued (9% of the total) had multiple complaints, none of which could be classified as primary. Where a primary reason for discontinuation could be identified, most patients discontinued because of nervous system complaints (5.4%), primarily <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>. The second-most-frequent reason for discontinuation was digestive system complaints (1.3%), primarily <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>.</p>
<p>There was no apparent relationship between the adverse events and elevated plasma drug concentrations.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_3c935f9d-ea82-44c5-9c86-d7c173dd2cb9"></a><a name="section-8.3"></a><p></p>
<h2>Incidence in Controlled Clinical Trials</h2>
<p class="First">The following table enumerates adverse events that occurred at an incidence of 1% or greater among patients with OCD who received clomipramine in adult or pediatric placebo-controlled clinical trials. The frequencies were obtained from pooled data of clinical trials involving either adults receiving clomipramine (N=322) or placebo (N=319) or children treated with clomipramine (N=46) or placebo (N=44). The prescriber should be aware that these figures cannot be used to predict the incidence of side effects in the course of usual medical practice, in which patient characteristics and other factors differ from those that prevailed in the clinical trials. Similarly, the cited frequencies cannot be compared with figures obtained from other clinical investigations involving different treatments, uses, and investigators. The cited figures, however, provide the physician with a basis for estimating the relative contribution of drug and nondrug factors to the incidence of side effects in the populations studied.</p>
<a name="_RefID0ENDAG"></a><table width="75%">
<caption><span>Incidence of Treatment-Emergent Adverse Experience in Placebo-Controlled Clinical Trials (Percentage of Patients Reporting Event)</span></caption>
<col width="21%">
<col width="17%">
<col width="10%">
<col width="17%">
<col width="10%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="left" valign="top"></th>
<th class="Botrule Rrule Toprule" align="left" colspan="2" valign="top"><span class="Bold">Adults</span></th>
<th class="Botrule Rrule Toprule" align="left" colspan="2" valign="top"><span class="Bold">Children and Adolescents</span></th>
</tr>
<tr class="Last">
<th class="Botrule Lrule Rrule" align="left" valign="top">
<span class="Bold">Body System/</span><br><span class="Bold">Adverse Event</span><a name="footnote-reference-1" href="#footnote-1" class="Sup">*</a>
</th>
<th class="Botrule Rrule" align="left" valign="top">
<span class="Bold">Clomipramine</span><br><span class="Bold">(N=322)</span>
</th>
<th class="Botrule Rrule" align="left" valign="top">
<span class="Bold">Placebo</span><br><span class="Bold">(N=319)</span>
</th>
<th class="Botrule Rrule" align="left" valign="top">
<span class="Bold">Clomipramine</span><br><span class="Bold">(N=46)</span>
</th>
<th class="Botrule Rrule" align="left" valign="top">
<span class="Bold">Placebo</span><br><span class="Bold">(N=44)</span>
</th>
</tr>
</thead>
<tfoot><tr><td colspan="5" align="left"><dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">*</a></dt>
<dd>Events reported by at least 1% of clomipramine patients are included.</dd>
</dl></td></tr></tfoot>
<tbody>
<tr class="First"><td class="Botrule Lrule Rrule Toprule" colspan="5" valign="top"><p class="First"><span class="Bold">Nervous System</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Somnolence</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">54</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">16</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">46</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">Tremor</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">54</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">33</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">54</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">41</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">52</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">41</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">28</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">34</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">Insomnia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">25</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">15</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Libido change</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">21</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">Nervousness</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">18</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="441553" conceptname="Myoclonus">Myoclonus</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">13</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4217027" conceptname="Increased appetite">Increased appetite</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">Paresthesia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4304008" conceptname="Memory impairment">Memory impairment</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">Anxiety</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4247265" conceptname="Muscle twitch">Twitching</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Impaired concentration</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4208994" conceptname="Increased muscle tone">Hypertonia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="435524" conceptname="Sleep disorder">Sleep disorder</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Psychosomatic disorder</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4089239" conceptname="Yawning">Yawning</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">Confusion</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Speech disorder</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Abnormal dreaming</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">Agitation</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">Migraine</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4085688" conceptname="Loss of identity">Depersonalization</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">Irritability</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4078201" conceptname="Mood swings">Emotional lability</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4196358" conceptname="Panic">Panic reaction</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4021344" conceptname="Abusive behavior">Aggressive reaction</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4154696" conceptname="Spastic paresis">Paresis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Skin and Appendages</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Increased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">29</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">8</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">Dermatitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">Acne</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">Dry skin</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Abnormal skin odor</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Digestive System</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">Dry mouth</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">84</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">17</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">63</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">16</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">Constipation</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">47</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">22</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">33</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Dyspepsia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">22</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">10</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">13</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">13</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">12</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">22</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal Pain</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">11</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">13</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">16</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">Flatulence</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4122115" conceptname="Tooth disorder">Tooth disorder</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">Gastrointestinal disorder</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">Dysphagia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="30753" conceptname="Esophagitis">Esophagitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4152350" conceptname="Burping">Eructation</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4160872" conceptname="Recurrent aphthous ulcer">Ulcerative stomatitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Body as a Whole</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">39</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">18</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">35</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">Weight increase</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">18</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">Flushing</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">8</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4113666" conceptname="Menopausal flushing">Hot flushes</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Chest pain</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Local <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Chills</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">Weight decrease</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="372328" conceptname="Otitis media">Otitis media</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">Asthenia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4195873" conceptname="Breath smells unpleasant">Halitosis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Cardiovascular System</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">Postural hypotension</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">Palpitation</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">Tachycardia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">Syncope</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Respiratory System</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">Pharyngitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">12</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">10</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4283893" conceptname="Sinusitis">Sinusitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Coughing</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">Bronchospasm</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="318556" conceptname="Epistaxis">Epistaxis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Dyspnea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="24969" conceptname="Laryngitis">Laryngitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Urogenital System</span><br><span class="Bold"><span class="Italics">Male and Female Patients Combined</span></span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Micturition disorder</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">Urinary tract infection</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Micturition frequency</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">Urinary retention</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">Dysuria</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">Cystitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Bold"><span class="Italics">Female Patients Only</span></span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=182)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=167)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=10)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=21)</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="194696" conceptname="Dysmenorrhea">Dysmenorrhea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">12</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">14</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">10</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">10</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Lactation (nonpuerperal)</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="196471" conceptname="Puberty bleeding">Menstrual disorder</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4081648" conceptname="Acute vaginitis">Vaginitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="195873" conceptname="Leukorrhea">Leukorrhea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="78474" conceptname="Hypertrophy of breast">Breast enlargement</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">Breast pain</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="443800" conceptname="Amenorrhea">Amenorrhea</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="Bold"><span class="Italics">Male Patients Only</span></span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=140)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=152)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=36)</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First"><span class="Bold">(N=23)</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4088757" conceptname="Anejaculation">Ejaculation failure</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">42</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">Impotence</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">20</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Special Senses</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="373786" conceptname="Abnormal vision">Abnormal vision</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">18</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">7</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">Taste perversion</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">8</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">Tinnitus</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">4</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Abnormal <span class="product-label-link" type="condition" conceptid="435553" conceptname="Epiphora">lacrimation</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">Mydriasis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">Conjunctivitis</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="434374" conceptname="Anisocoria">Anisocoria</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="435802" conceptname="Blepharospasm">Blepharospasm</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First">Ocular <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="81303" conceptname="Labyrinthine disorder">Vestibular disorder</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Musculoskeletal</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">13</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">9</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">Back pain</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">6</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">5</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">Muscle weakness</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">1</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Hemic and Lymphatic</span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">Purpura</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">3</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">Anemia</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
<tr><td class="Botrule Lrule Rrule" colspan="5" valign="top"><p class="First"><span class="Bold">Metabolic and Nutritional</span></p></td></tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" valign="top"><p class="First"><span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">Thirst</span></p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">-</p></td>
<td class="Botrule Rrule" valign="top"><p class="First">2</p></td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_1f5330b7-c2ae-4aba-bfdf-57b2d7280092"></a><a name="section-8.4"></a><p></p>
<h2>Other Events Observed During the Premarketing Evaluation of Clomipramine</h2>
<p class="First">During clinical testing in the U.S., multiple doses of clomipramine hydrochloride capsules USP were administered to approximately 3600 subjects. Untoward events associated with this exposure were recorded by clinical investigators using terminology of their own choosing. Consequently, it is not possible to provide a meaningful estimate of the proportion of individuals experiencing adverse events without first grouping similar types of untoward events into a smaller number of standardized event categories.</p>
<p>In the tabulations that follow, a modified World Health Organization dictionary of terminology has been used to classify reported adverse events. The frequencies presented, therefore, represent the proportion of the 3525 individuals exposed to clomipramine who experienced an event of the type cited on at least one occasion while receiving clomipramine. All events are included except those already listed in the previous table, those reported in terms so general as to be uninformative, and those in which an association with the drug was remote. It is important to emphasize that although the events reported occurred during treatment with clomipramine, they were not necessarily caused by it.</p>
<p>Events are further categorized by body system and listed in order of decreasing frequency according to the following definitions: frequent adverse events are those occurring on one or more occasions in at least 1/100 patients; infrequent adverse events are those occurring in 1/100 to 1/1000 patients; rare events are those occurring in less than 1/1000 patients.</p>
<p><span class="Bold">Body as a Whole- </span><span class="Italics">Infrequent </span>- general <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, increased susceptibility to <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="4087149" conceptname="Dependent edema">dependent edema</span>, withdrawal syndrome.</p>
<p><span class="Bold">Cardiovascular System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="320536" conceptname="Electrocardiogram abnormal">abnormal ECG</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmia</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>, <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>, <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>.<span class="Italics"> Rare </span>- <span class="product-label-link" type="condition" conceptid="4311963" conceptname="Aneurysm">aneurysm</span>, <span class="product-label-link" type="condition" conceptid="314665" conceptname="Atrial flutter">atrial flutter</span>, <span class="product-label-link" type="condition" conceptid="313791" conceptname="Bundle branch block">bundle branch block</span>, <span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">cardiac failure</span>, <span class="product-label-link" type="condition" conceptid="376713" conceptname="Cerebral hemorrhage">cerebral hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">myocardial infarction</span>, <span class="product-label-link" type="condition" conceptid="4124683" conceptname="Silent myocardial ischemia">myocardial ischemia</span>, <span class="product-label-link" type="condition" conceptid="4124836" conceptname="Peripheral ischemia">peripheral ischemia</span>, <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span>, <span class="product-label-link" type="condition" conceptid="4215494" conceptname="Vasospasm">vasospasm</span>, <span class="product-label-link" type="condition" conceptid="4103295" conceptname="Ventricular tachycardia">ventricular tachycardia</span>.</p>
<p><span class="Bold">Digestive System- </span><span class="Italics">Infrequent </span>- abnormal hepatic function, <span class="product-label-link" type="condition" conceptid="443530" conceptname="Hematochezia">blood in stool</span>, <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>, <span class="product-label-link" type="condition" conceptid="433516" conceptname="Duodenitis">duodenitis</span>, <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">gastric ulcer</span>, <span class="product-label-link" type="condition" conceptid="201340" conceptname="Gastritis">gastritis</span>, <span class="product-label-link" type="condition" conceptid="318800" conceptname="Gastroesophageal reflux disease">gastroesophageal reflux</span>, <span class="product-label-link" type="condition" conceptid="4281516" conceptname="Gingivitis">gingivitis</span>, <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="194382" conceptname="External hemorrhoids">hemorrhoids</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, increased saliva, <span class="product-label-link" type="condition" conceptid="75576" conceptname="Irritable bowel syndrome">irritable bowel syndrome</span>, <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, <span class="product-label-link" type="condition" conceptid="197925" conceptname="Hemorrhage of rectum and anus">rectal hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="4278836" conceptname="Ulcer on tongue">tongue ulceration</span>, <span class="product-label-link" type="condition" conceptid="133228" conceptname="Dental caries">tooth caries</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="4301764" conceptname="Cheilitis">cheilitis</span>, chronic <span class="product-label-link" type="condition" conceptid="201773" conceptname="Enteritis of small intestine">enteritis</span>, discolored feces, <span class="product-label-link" type="condition" conceptid="195301" conceptname="Acute dilatation of stomach">gastric dilatation</span>, <span class="product-label-link" type="condition" conceptid="4311406" conceptname="Bleeding gums">gingival bleeding</span>, <span class="product-label-link" type="condition" conceptid="194475" conceptname="Hiccoughs">hiccup</span>, <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>, oral/<span class="product-label-link" type="condition" conceptid="4056883" conceptname="Edema of pharynx">pharyngeal edema</span>, <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>, <span class="product-label-link" type="condition" conceptid="28461" conceptname="Hypertrophy of salivary gland">salivary gland enlargement</span>.</p>
<p><span class="Bold">Endocrine System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span>, <span class="product-label-link" type="condition" conceptid="4168447" conceptname="Gynecomastia">gynecomastia</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>.</p>
<p><span class="Bold">Hemic and Lymphatic System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="432283" conceptname="Leukemoid reaction">leukemoid reaction</span>, <span class="product-label-link" type="condition" conceptid="4027114" conceptname="Pseudolymphoma">lymphoma-like disorder</span>, <span class="product-label-link" type="condition" conceptid="4145241" conceptname="Bone marrow depression">marrow depression</span>.</p>
<p><span class="Bold">Metabolic and Nutritional Disorder- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus, <span class="product-label-link" type="condition" conceptid="440674" conceptname="Gout">gout</span>, <span class="product-label-link" type="condition" conceptid="437827" conceptname="Pure hypercholesterolemia">hypercholesterolemia</span>, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, <span class="product-label-link" type="condition" conceptid="4147761" conceptname="Hyperuricemia">hyperuricemia</span>, <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>.<span class="Italics"> Rare </span>- fat intolerance, <span class="product-label-link" type="condition" conceptid="434164" conceptname="Glycosuria">glycosuria</span>.</p>
<p><span class="Bold">Musculoskeletal System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="73553" conceptname="Arthropathy">arthrosis</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="375800" conceptname="Dystonia">dystonia</span>, <span class="product-label-link" type="condition" conceptid="72715" conceptname="Exostosis">exostosis</span>, <span class="product-label-link" type="condition" conceptid="255891" conceptname="Lupus erythematosus">lupus erythematosus</span> <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="441737" conceptname="Contusion">bruising</span>, <span class="product-label-link" type="condition" conceptid="137275" conceptname="Disorder of muscle">myopathy</span>, <span class="product-label-link" type="condition" conceptid="73001" conceptname="Myositis">myositis</span>, <span class="product-label-link" type="condition" conceptid="320749" conceptname="Polyarteritis nodosa">polyarteritis nodosa</span>, <span class="product-label-link" type="condition" conceptid="440814" conceptname="Torticollis">torticollis</span>.</p>
<p><span class="Bold">Nervous System- </span><span class="Italics">Frequent </span>- <span class="product-label-link" type="condition" conceptid="4131797" conceptname="Disturbance in thinking">abnormal thinking</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>. <span class="Italics">Infrequent </span>- abnormal coordination, <span class="product-label-link" type="condition" conceptid="4168553" conceptname="Electroencephalogram abnormal">abnormal EEG</span>, <span class="product-label-link" type="condition" conceptid="437643" conceptname="Abnormal gait">abnormal gait</span>, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">apathy</span>, <span class="product-label-link" type="condition" conceptid="437584" conceptname="Ataxia">ataxia</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span>, <span class="product-label-link" type="condition" conceptid="444401" conceptname="Delusions">delusion</span>, <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span>, <span class="product-label-link" type="condition" conceptid="432730" conceptname="Difficulty speaking">dysphonia</span>, <span class="product-label-link" type="condition" conceptid="372887" conceptname="Disorder of brain">encephalopathy</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="373747" conceptname="Extrapyramidal disease">extrapyramidal disorder</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="4195585" conceptname="Hostile behavior">hostility</span>, <span class="product-label-link" type="condition" conceptid="4195305" conceptname="Hyperactive behavior">hyperkinesia</span>, <span class="product-label-link" type="condition" conceptid="4264363" conceptname="Hypnagogic hallucinations">hypnagogic hallucinations</span>, <span class="product-label-link" type="condition" conceptid="4195475" conceptname="Behavior showing reduced motor activity">hypokinesia</span>, <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">leg cramps</span>, <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">manic reaction</span>, <span class="product-label-link" type="condition" conceptid="373852" conceptname="Neuralgia">neuralgia</span>, <span class="product-label-link" type="condition" conceptid="432590" conceptname="Delusional disorder">paranoia</span>, <span class="product-label-link" type="condition" conceptid="440985" conceptname="Phobia">phobic disorder</span>, <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychosis</span>, <span class="product-label-link" type="condition" conceptid="4311114" conceptname="Sensory disorder">sensory disturbance</span>, <span class="product-label-link" type="condition" conceptid="377535" conceptname="Sleep walking disorder">somnambulism</span>, stimulation, <span class="product-label-link" type="condition" conceptid="4092095" conceptname="Planning suicide">suicidal ideation</span>, <span class="product-label-link" type="condition" conceptid="4219484" conceptname="Suicide attempt">suicide attempt</span>, teeth-grinding. <span class="Italics">Rare </span>- anticholinergic syndrome, <span class="product-label-link" type="condition" conceptid="440424" conceptname="Aphasia">aphasia</span>, <span class="product-label-link" type="condition" conceptid="132342" conceptname="Apraxia">apraxia</span>, <span class="product-label-link" type="condition" conceptid="4045422" conceptname="Waxy flexibility">catalepsy</span>, <span class="product-label-link" type="condition" conceptid="440895" conceptname="Poisoning by parasympathomimetic drug">cholinergic syndrome</span>, <span class="product-label-link" type="condition" conceptid="4181630" conceptname="Choreoathetosis">choreoathetosis</span>, <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">generalized spasm</span>, <span class="product-label-link" type="condition" conceptid="4065756" conceptname="Hemiparesis">hemiparesis</span>, <span class="product-label-link" type="condition" conceptid="4031840" conceptname="Hyperesthesia">hyperesthesia</span>, <span class="product-label-link" type="condition" conceptid="4313132" conceptname="Hyperreflexia">hyperreflexia</span>, <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">hypoesthesia</span>, <span class="product-label-link" type="condition" conceptid="4238753" conceptname="Optical illusion">illusion</span>, impaired impulse control, indecisiveness, <span class="product-label-link" type="condition" conceptid="4339188" conceptname="Mutism">mutism</span>, <span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span>, <span class="product-label-link" type="condition" conceptid="378165" conceptname="Nystagmus">nystagmus</span>, <span class="product-label-link" type="condition" conceptid="4205592" conceptname="Oculogyric crisis">oculogyric crisis</span>, oculomotor <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">nerve paralysis</span>, <span class="product-label-link" type="condition" conceptid="444434" conceptname="Schizophreniform disorder">schizophrenic reaction</span>, <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span>, <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>.</p>
<p><span class="Bold">Respiratory System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="256451" conceptname="Bronchitis">bronchitis</span>, <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span>, increased <span class="product-label-link" type="condition" conceptid="4102774" conceptname="Productive cough">sputum</span>, <span class="product-label-link" type="condition" conceptid="255848" conceptname="Pneumonia">pneumonia</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>, <span class="product-label-link" type="condition" conceptid="261687" conceptname="Hemoptysis">hemoptysis</span>, <span class="product-label-link" type="condition" conceptid="312603" conceptname="Hypoventilation">hypoventilation</span>, <span class="product-label-link" type="condition" conceptid="437904" conceptname="Laryngeal spasm">laryngismus</span>.</p>
<p><span class="Bold">Skin and Appendages- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">alopecia</span>, <span class="product-label-link" type="condition" conceptid="435613" conceptname="Cellulitis">cellulitis</span>, <span class="product-label-link" type="condition" conceptid="4209224" conceptname="Cyst">cyst</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>, erythematous <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4146239" conceptname="Pruritus of genital organs">genital pruritus</span>, <span class="product-label-link" type="condition" conceptid="4083795" conceptname="Maculopapular eruption">maculopapular rash</span>, <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">photosensitivity reaction</span>, <span class="product-label-link" type="condition" conceptid="140168" conceptname="Psoriasis">psoriasis</span>, <span class="product-label-link" type="condition" conceptid="4158333" conceptname="Pustule">pustular rash</span>, <span class="product-label-link" type="condition" conceptid="135030" conceptname="Discoloration of skin">skin discoloration</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="4264234" conceptname="Chloasma">chloasma</span>, <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>, <span class="product-label-link" type="condition" conceptid="443793" conceptname="Hypertrichosis">hypertrichosis</span>, <span class="product-label-link" type="condition" conceptid="4224957" conceptname="Piloerection">piloerection</span>, <span class="product-label-link" type="condition" conceptid="138821" conceptname="Seborrhea">seborrhea</span>, skin <span class="product-label-link" type="condition" conceptid="4210465" conceptname="Hypertrophy">hypertrophy</span>, <span class="product-label-link" type="condition" conceptid="4262920" conceptname="Skin ulcer">skin ulceration</span>.</p>
<p><span class="Bold">Special Senses- </span><span class="Italics">Infrequent </span>- abnormal accommodation, <span class="product-label-link" type="condition" conceptid="377889" conceptname="Hearing loss">deafness</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, <span class="product-label-link" type="condition" conceptid="380733" conceptname="Otalgia">earache</span>, <span class="product-label-link" type="condition" conceptid="379031" conceptname="Pain in eye">eye pain</span>, foreign body sensation, <span class="product-label-link" type="condition" conceptid="378163" conceptname="Hyperacusis">hyperacusis</span>, <span class="product-label-link" type="condition" conceptid="444223" conceptname="Sense of smell altered">parosmia</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, <span class="product-label-link" type="condition" conceptid="434944" conceptname="Scleritis">scleritis</span>, <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">taste loss</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="378425" conceptname="Blepharitis">blepharitis</span>, <span class="product-label-link" type="condition" conceptid="4092111" conceptname="Chromatopsia">chromatopsia</span>, <span class="product-label-link" type="condition" conceptid="378756" conceptname="Conjunctival hemorrhage">conjunctival hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="436700" conceptname="Exophthalmos">exophthalmos</span>, <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>, labyrinth disorder, <span class="product-label-link" type="condition" conceptid="374037" conceptname="Night blindness">night blindness</span>, <span class="product-label-link" type="condition" conceptid="378416" conceptname="Retinal disorder">retinal disorder</span>, <span class="product-label-link" type="condition" conceptid="4329707" conceptname="Strabismus">strabismus</span>, <span class="product-label-link" type="condition" conceptid="377286" conceptname="Visual field defect">visual field defect</span>.</p>
<p><span class="Bold">Urogenital System- </span><span class="Italics">Infrequent </span>- <span class="product-label-link" type="condition" conceptid="433527" conceptname="Endometriosis">endometriosis</span>, <span class="product-label-link" type="condition" conceptid="4150043" conceptname="Epididymitis">epididymitis</span>, <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">hematuria</span>, <span class="product-label-link" type="condition" conceptid="40304526" conceptname="Nocturia">nocturia</span>, <span class="product-label-link" type="condition" conceptid="4306451" conceptname="Oliguria">oliguria</span>, <span class="product-label-link" type="condition" conceptid="193530" conceptname="Follicular cyst of ovary">ovarian cyst</span>, <span class="product-label-link" type="condition" conceptid="4021670" conceptname="Perineal pain">perineal pain</span>, <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>, <span class="product-label-link" type="condition" conceptid="196734" conceptname="Disorder of prostate">prostatic disorder</span>, <span class="product-label-link" type="condition" conceptid="201620" conceptname="Kidney stone">renal calculus</span>, <span class="product-label-link" type="condition" conceptid="4167250" conceptname="Renal pain">renal pain</span>, <span class="product-label-link" type="condition" conceptid="196156" conceptname="Urethral diverticulum">urethral disorder</span>, <span class="product-label-link" type="condition" conceptid="197672" conceptname="Urinary incontinence">urinary incontinence</span>, <span class="product-label-link" type="condition" conceptid="195876" conceptname="Hematometra">uterine hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="4129155" conceptname="Vaginal bleeding">vaginal hemorrhage</span>. <span class="Italics">Rare </span>- <span class="product-label-link" type="condition" conceptid="4168705" conceptname="Albuminuria">albuminuria</span>, anorgasmy, <span class="product-label-link" type="condition" conceptid="80478" conceptname="Engorgement of breasts associated with childbirth">breast engorgement</span>, <span class="product-label-link" type="condition" conceptid="4116072" conceptname="Fibroadenoma of breast">breast fibroadenosis</span>, <span class="product-label-link" type="condition" conceptid="192367" conceptname="Dysplasia of cervix">cervical dysplasia</span>, <span class="product-label-link" type="condition" conceptid="200775" conceptname="Endometrial hyperplasia">endometrial hyperplasia</span>, <span class="product-label-link" type="condition" conceptid="434319" conceptname="Premature ejaculation">premature ejaculation</span>, <span class="product-label-link" type="condition" conceptid="198199" conceptname="Pyelonephritis">pyelonephritis</span>, <span class="product-label-link" type="condition" conceptid="4167328" conceptname="Pyuria">pyuria</span>, <span class="product-label-link" type="condition" conceptid="196813" conceptname="Simple renal cyst">renal cyst</span>, <span class="product-label-link" type="condition" conceptid="4035007" conceptname="Metritis">uterine inflammation</span>, vulvar disorder.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_bf1363a1-eebe-4ac0-bb9a-4776effafcaa"></a><a name="section-8.5"></a><p></p>
<h2>Postmarketing Experience</h2>
<p class="First">The following adverse drug reaction has been reported during post-approval use of clomipramine. Because this reaction is reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate frequency.</p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="375252" conceptname="Disorder of eye">Eye Disorders</span> –</span> angle-closure <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="DAAD"></a><a name="section-9"></a><p></p>
<h1>DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></h1>
<p class="First">Clomipramine has not been systematically studied in animals or humans for its potential for abuse, tolerance, or physical <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span>. While a variety of withdrawal symptoms have been described in association with clomipramine discontinuation (<span class="Italics">see </span><span class="Bold"><a href="#WS">PRECAUTIONS, Withdrawal Symptoms</a></span>), there is no evidence for drug-seeking behavior, except for a single report of potential clomipramine abuse by a patient with a history of <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> on codeine, benzodiazepines, and multiple psychoactive drugs. The patient received clomipramine for <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and <span class="product-label-link" type="condition" conceptid="4021498" conceptname="Panic attack">panic attacks</span> and appeared to become dependent after hospital discharge.</p>
<p>Despite the lack of evidence suggesting an abuse liability for clomipramine in foreign marketing, it is not possible to predict the extent to which clomipramine might be misused or abused once marketed in the U.S. Consequently, physicians should carefully evaluate patients for a history of drug abuse and follow such patients closely.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="ID_f4cd8188-73de-44de-8ae3-bc81e4a5bd17"></a><a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> may occur from overdosage with this class of drugs. Multiple drug ingestion (including alcohol) is common in deliberate tricyclic <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>. As the management is complex and changing, it is recommended that the physician contact a poison control center for current information on treatment. Signs and symptoms of toxicity develop rapidly after tricyclic <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>. Therefore, hospital monitoring is required as soon as possible.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_97c49661-958b-42a7-b7b0-0c88a641c760"></a><a name="section-10.1"></a><p></p>
<h2>Human Experience</h2>
<p class="First">In U.S. clinical trials, 2 <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span> occurred in 12 reported cases of acute overdosage with clomipramine either alone or in combination with other drugs. One <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> involved a patient suspected of ingesting a dose of 7000 mg. The second <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> involved a patient suspected of ingesting a dose of 5750 mg. The 10 nonfatal cases involved doses of up to 5000 mg, accompanied by plasma levels of up to 1010 ng/mL. All 10 patients completely recovered. Among reports from other countries of clomipramine <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, the lowest dose associated with a fatality was 750 mg. Based upon postmarketing reports in the United Kingdom, CMI's lethality in <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> is considered to be similar to that reported for closely related tricyclic compounds marketed as antidepressants.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_3a296f1c-a162-494c-b3c4-de5db9183abf"></a><a name="section-10.2"></a><p></p>
<h2>Manifestations</h2>
<p class="First">Signs and symptoms vary in severity depending upon factors such as the amount of drug absorbed, the age of the patient, and the time elapsed since drug ingestion. Critical manifestations of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> include <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac dysrhythmias</span>, severe <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, and <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> including <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>. Changes in the electrocardiogram, particularly in QRS axis or width, are clinically significant indicators of tricyclic toxicity. Other CNS manifestations may include <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span>, <span class="product-label-link" type="condition" conceptid="437584" conceptname="Ataxia">ataxia</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span>, severe perspiration, <span class="product-label-link" type="condition" conceptid="4137162" conceptname="Overactive">hyperactive</span> reflexes, <span class="product-label-link" type="condition" conceptid="4050941" conceptname="Muscle rigidity">muscle rigidity</span>, and <span class="product-label-link" type="condition" conceptid="4259277" conceptname="Athetosis">athetoid</span> and choreiform movements. Cardiac abnormalities may include <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, signs of <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, and in very rare cases, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory depression</span>, <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4260205" conceptname="Hyperpyrexia">hyperpyrexia</span>, <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span> and <span class="product-label-link" type="condition" conceptid="4306451" conceptname="Oliguria">oliguria</span> or <span class="product-label-link" type="condition" conceptid="4090272" conceptname="Anuria">anuria</span>, may also be present.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_2bbcabc7-4475-451e-a10c-4854dd401982"></a><a name="section-10.3"></a><p></p>
<h2>Management</h2>
<p class="First">Obtain an ECG and immediately initiate cardiac monitoring. Protect the patient's airway, establish an intravenous line, and initiate gastric decontamination. A minimum of 6 hours of observation with cardiac monitoring and observation for signs of CNS or <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac dysrhythmias</span> and/or conduction blocks, and <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> is necessary.</p>
<p>If signs of toxicity occur at any time during this period, extended monitoring is required. There are case reports of patients succumbing to fatal <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">dysrhythmias</span> late after <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>; these patients had clinical evidence of significant <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span> prior to <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> and most received inadequate gastrointestinal decontamination. Monitoring of plasma drug levels should not guide management of the patient.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_03b015d2-63ee-4b4a-9c1b-b81315a29f69"></a><a name="section-10.3.1"></a><p></p>
<h3>Gastrointestinal Decontamination</h3>
<p class="First">All patients suspected of tricyclic <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> should receive gastrointestinal decontamination. This should include large volume gastric lavage followed by activated charcoal. If consciousness is impaired, the airway should be secured prior to lavage. <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Emesis</span> is contraindicated.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_8fff6bbe-2519-4901-aba4-3ce642983138"></a><a name="section-10.3.2"></a><p></p>
<h3>Cardiovascular</h3>
<p class="First">A maximal limb-lead QRS duration of ≥ 0.10 seconds may be the best indication of the severity of the <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>. Intravenous sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> should be used to maintain the serum pH in the range of 7.45 to 7.55. If the pH response is inadequate, <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span> may also be used. Concomitant use of <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span> and sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> should be done with extreme caution, with frequent pH monitoring. A pH &gt;7.60 or a pCO<span class="Sub">2</span> &lt; 20 mmHg is undesirable. <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Dysrhythmias</span> unresponsive to sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> therapy/<span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span> may respond to lidocaine, bretylium, or phenytoin. Type 1A and 1C antiarrhythmics are generally contraindicated (e.g., quinidine, disopyramide, and procainamide).</p>
<p>In rare instances, hemoperfusion may be beneficial in acute refractory cardiovascular instability in patients with acute toxicity. However, hemodialysis, peritoneal dialysis, exchange transfusions, and forced <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> generally have been reported as ineffective in tricyclic <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_ce2062e2-cd6e-4b00-a2f5-5ee476dcc05e"></a><a name="section-10.3.3"></a><p></p>
<h3>CNS</h3>
<p class="First">In patients with <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>, early intubation is advised because of the potential for abrupt deterioration. <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span> should be controlled with benzodiazepines, or if these are ineffective, other anticonvulsants (e.g., phenobarbital, phenytoin). Physostigmine is not recommended except to treat life-threatening symptoms that have been unresponsive to other therapies, and then only in consultation with a poison control center.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_0761de9b-b0ba-40f1-881f-e598180066e7"></a><a name="section-10.3.4"></a><p></p>
<h3>Psychiatric Follow-up</h3>
<p class="First">Since overdosage is often deliberate, patients may attempt <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span> by other means during the recovery phase. Psychiatric referral may be appropriate.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_6ed696f5-3976-4ac8-bcb9-c8ad4afe3d48"></a><a name="section-10.3.5"></a><p></p>
<h3>Pediatric Management</h3>
<p class="First">The principles of management of child and adult overdosages are similar. It is strongly recommended that the physician contact the local poison control center for specific pediatric treatment.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="DAA"></a><a name="section-11"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The treatment regimens described below are based on those used in controlled clinical trials of clomipramine in 520 adults, and 91 children and adolescents with OCD. During initial titration, clomipramine should be given in divided doses with meals to reduce gastrointestinal side effects. The goal of this initial titration phase is to minimize side effects by permitting tolerance to side effects to develop or allowing the patient time to adapt if tolerance does not develop.</p>
<p>Because both CMI and its active metabolite, DMI, have long elimination half-lives, the prescriber should take into consideration the fact that steady-state plasma levels may not be achieved until 2 to 3 weeks after dosage change (<span class="Italics">see </span><span class="Bold"><a href="#CP">CLINICAL PHARMACOLOGY</a></span>). Therefore, after initial titration, it may be appropriate to wait 2 to 3 weeks between further dosage adjustments.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_d6f08aa6-ea73-47af-bc05-8aebc2dc84a1"></a><a name="section-11.1"></a><p></p>
<h2>Initial Treatment/Dose Adjustment (Adults)</h2>
<p class="First">Treatment with clomipramine should be initiated at a dosage of 25 mg daily and gradually increased, as tolerated, to approximately 100 mg during the first 2 weeks. During initial titration, clomipramine should be given in divided doses with meals to reduce gastrointestinal side effects. Thereafter, the dosage may be increased gradually over the next several weeks, up to a maximum of 250 mg daily. After titration, the total daily dose may be given once daily at bedtime to minimize daytime sedation.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_c463a202-1117-4e45-b83b-35838e3a4981"></a><a name="section-11.2"></a><p></p>
<h2>Initial Treatment/Dose Adjustment (Children and Adolescents)</h2>
<p class="First">As with adults, the starting dose is 25 mg daily and should be gradually increased (also given in divided doses with meals to reduce gastrointestinal side effects) during the first 2 weeks, as tolerated, up to a daily maximum of 3 mg/kg or 100 mg, whichever is smaller. Thereafter, the dosage may be increased gradually over the next several weeks up to a daily maximum of 3 mg/kg or 200 mg, whichever is smaller (<span class="Italics">see </span><span class="Bold"><a href="#P_Ped">PRECAUTIONS, Pediatric Use</a></span>). As with adults, after titration, the total daily dose may be given once daily at bedtime to minimize daytime sedation.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_98cd3fe8-e0cd-4d88-8df5-8e6436661233"></a><a name="section-11.3"></a><p></p>
<h2>Maintenance/Continuation Treatment (Adults, Children, and Adolescents)</h2>
<p class="First">While there are no systematic studies that answer the question of how long to continue clomipramine, OCD is a chronic condition and it is reasonable to consider continuation for a responding patient. Although the efficacy of clomipramine after 10 weeks has not been documented in controlled trials, patients have been continued in therapy under double-blind conditions for up to 1 year without loss of benefit. However, dosage adjustments should be made to maintain the patient on the lowest effective dosage, and patients should be periodically reassessed to determine the need for treatment. During maintenance, the total daily dose may be given once daily at bedtime.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_801398fd-cb04-4f27-9b6a-29a3d95314dc"></a><a name="section-11.4"></a><p></p>
<h2>Switching a Patient To or From a Monoamine Oxidase Inhibitor (MAOI) Intended to Treat Psychiatric Disorders</h2>
<p class="First">At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with clomipramine. Conversely, at least 14 days should be allowed after stopping clomipramine before starting an MAOI intended to treat psychiatric disorders (<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_23967aa2-e889-4895-9660-40b98f0a84f2"></a><a name="section-11.5"></a><p></p>
<h2>Use of Clomipramine With Other MAOIs, Such as Linezolid or Methylene Blue</h2>
<p class="First">Do not start clomipramine in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span>. In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered (<span class="Italics">see </span><span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a></span>).</p>
<p>In some cases, a patient already receiving clomipramine therapy may require urgent treatment with linezolid or intravenous methylene blue. If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span> in a particular patient, clomipramine should be stopped promptly, and linezolid or intravenous methylene blue can be administered. The patient should be monitored for symptoms of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span> for two weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first. Therapy with clomipramine may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span>).</p>
<p>The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with clomipramine is unclear. The clinician should, nevertheless, be aware of the possibility of emergent symptoms of <span class="product-label-link" type="condition" conceptid="4154707" conceptname="Serotonin syndrome">serotonin syndrome</span> with such use (<span class="Italics">see </span><span class="Bold"><a href="#warnings">WARNINGS</a></span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_797dc9ac-b233-4cb4-ae23-7ff764b292cf"></a><a name="section-12"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Clomipramine Hydrochloride Capsules USP are supplied as follows:</p>
<p><span class="Italics">25 mg </span>- Dark blue cap/light blue body capsules, size 2, with black printing of CLOM 25 on both cap and body of capsule</p>
<table width="50%">
<col width="21%">
<col width="29%">
<tbody class="Headless">
<tr class="First">
<td class="Toprule" valign="top"><p class="First">Bottles of 30</p></td>
<td class="Toprule" valign="top"><p class="First">NDC 60429-287-30</p></td>
</tr>
<tr>
<td valign="top"><p class="First">Bottles of 90</p></td>
<td valign="top"><p class="First">NDC 60429-287-90</p></td>
</tr>
<tr class="Last">
<td class="Botrule" valign="top"><p class="First">Bottles of 100</p></td>
<td class="Botrule" valign="top"><p class="First">NDC 60429-287-01</p></td>
</tr>
</tbody>
</table>
<p><span class="Italics"><br>75 mg </span>- White opaque capsules, size 1, with black printing of CLOM 75 on both cap and body of capsule</p>
<table width="50%">
<col width="21%">
<col width="29%">
<tbody class="Headless">
<tr class="First">
<td class="Toprule" valign="top"><p class="First">Bottles of 30</p></td>
<td class="Toprule" valign="top"><p class="First">NDC 60429-288-30</p></td>
</tr>
<tr>
<td valign="top"><p class="First">Bottles of 90</p></td>
<td valign="top"><p class="First">NDC 60429-288-90</p></td>
</tr>
<tr class="Last">
<td class="Botrule" valign="top"><p class="First">Bottles of 100</p></td>
<td class="Botrule" valign="top"><p class="First">NDC 60429-288-01</p></td>
</tr>
</tbody>
</table>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_dbef1e3d-2187-4e66-8c47-09b2baa5d121"></a><a name="section-12.1"></a><p></p>
<p class="First"><span class="Bold">Store at 20°-25°C (68°-77°F) </span>[see USP Controlled Room Temperature]. Dispense in well-closed containers with a child-resistant closure. Protect from moisture.</p>
</div>
</div>
<div class="Section" data-sectionCode="34091-9">
<a name="ID_ea30879b-03d4-421c-a500-4a42b1832fc1"></a><a name="section-13"></a><p></p>
<h1>ANIMAL TOXICOLOGY</h1>
<p class="First">Phospholipidosis and testicular changes commonly associated with tricyclic compounds, have been observed with clomipramine. In chronic rat studies, changes related to clomipramine consisted of systemic phospholipidosis, alteration in the testes (<span class="product-label-link" type="condition" conceptid="4028206" conceptname="Atrophy">atrophy</span>, mineralization) and secondary changes in other tissues. In addition cardiac <span class="product-label-link" type="condition" conceptid="4130722" conceptname="Thrombosis">thrombosis</span> and <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>/<span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span> were observed in rats treated for 2 years at doses which were 24 and 10 times the maximum recommended human daily dose (MRHD), respectively, on a mg/kg basis, and 4 and 1.5 times the MRHD, respectively, on a mg/m<span class="Sup">2</span> basis.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_1fd50151-a8b4-4cea-8e66-f721b3c85077"></a><a name="section-14"></a><p></p>
<p class="First">Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761<br>Dist. by:<span class="Bold"> Taro Pharmaceuticals U.S.A., Inc.</span>, Hawthorne, NY 10532<br>Marketed/ Packaged by: GSMS, Inc. Camarillo, CA 93012 USA<br>Revised: July 2014</p>
</div>
<div class="Section" data-sectionCode="42231-1">
<a name="ID_122a994d-c00f-445e-8aea-e303d0e45175"></a><a name="section-15"></a><p></p>
<h1>Medication Guide</h1>
<p class="First"><span class="Bold">Clomipramine Hydrochloride Capsules USP</span></p>
<p><span class="Bold">Antidepressant Medicines, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span> and other Serious Mental Illnesses, and Suicidal Thoughts or Actions</span></p>
<p>Read the Medication Guide that comes with you or your family member's antidepressant medicine. This Medication Guide is only about the risk of suicidal thoughts and actions with antidepressant medicines.<span class="Bold"> Talk to your, or your family member's, healthcare provider about:</span></p>
<dl>
<dt>•</dt>
<dd>all risks and benefits of treatment with antidepressant medicines</dd>
<dt>•</dt>
<dd>all treatment choices for <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> or other serious mental illness</dd>
</dl>
<p><span class="Bold">What is the most important information I should know about antidepressant medicines, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and other serious mental illnesses, and suicidal thoughts or actions?</span></p>
<dl>
<dt>•</dt>
<dd><span class="Bold">Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.</span></dd>
<dt>•</dt>
<dd>
<span class="Bold"><span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span> and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a particularly high risk of having suicidal thoughts or actions.</span> These include people who have (or have a family history of) bipolar illness (also called <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">manic</span>-<span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depressive illness</span>) or suicidal thoughts or actions.</dd>
<dt>•</dt>
<dd>
<span class="Bold">How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?</span><dl>
<dt>•</dt>
<dd>Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. This is very important when an antidepressant medicine is started or when the dose is changed.</dd>
<dt>•</dt>
<dd>Call the healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.</dd>
<dt>•</dt>
<dd>Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.</dd>
</dl>
</dd>
</dl>
<p><span class="Bold">Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">worry</span> you:</span></p>
<dl>
<dt>•</dt>
<dd>thoughts about <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span> or dying</dd>
<dt>•</dt>
<dd>attempts to commit <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span></dd>
<dt>•</dt>
<dd>new or worse <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span></dd>
<dt>•</dt>
<dd>new or worse <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span></dd>
<dt>•</dt>
<dd>feeling very <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitated</span> or <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restless</span></dd>
<dt>•</dt>
<dd><span class="product-label-link" type="condition" conceptid="4021498" conceptname="Panic attack">panic attacks</span></dd>
<dt>•</dt>
<dd>trouble sleeping (<span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>)</dd>
<dt>•</dt>
<dd>new or worse <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span></dd>
<dt>•</dt>
<dd>acting aggressive, being angry, or violent</dd>
<dt>•</dt>
<dd>acting on dangerous impulses</dd>
<dt>•</dt>
<dd>an extreme increase in activity and talking (<span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">mania</span>)</dd>
<dt>•</dt>
<dd>other unusual changes in behavior or mood</dd>
</dl>
<p><span class="Bold">Visual problems</span></p>
<dl>
<dt>•</dt>
<dd><span class="product-label-link" type="condition" conceptid="379031" conceptname="Pain in eye">eye pain</span></dd>
<dt>•</dt>
<dd>changes in vision</dd>
<dt>•</dt>
<dd><span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> or <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> in or around the eye</dd>
</dl>
<p>Only some people are at risk for these problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are.</p>
<p><span class="Bold">Who should not take clomipramine hydrochloride capsules, USP?</span></p>
<p>Do not take clomipramine if you:</p>
<dl>
<dt>•</dt>
<dd>take a monoamine oxidase inhibitor (MAOI). Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid.<dl>
<dt>•</dt>
<dd>Do not take an MAOI within 2 weeks of stopping clomipramine unless directed to do so by your physician.</dd>
<dt>•</dt>
<dd>Do not start clomipramine if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician.</dd>
</dl>
</dd>
</dl>
<p><span class="Bold">What else do I need to know about antidepressant medicines?</span></p>
<dl>
<dt>•</dt>
<dd>
<span class="Bold">Never stop an antidepressant medicine without first talking to a healthcare provider.</span> Stopping an antidepressant medicine suddenly can cause other symptoms.</dd>
<dt>•</dt>
<dd>
<span class="Bold">Antidepressants are medicines used to treat <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and other illnesses. </span>It is important to discuss all the risks of treating <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> and also the risks of not treating it. Patients and their families or other caregivers should discuss all treatment choices with the healthcare provider, not just the use of antidepressants.</dd>
<dt>•</dt>
<dd>
<span class="Bold">Antidepressant medicines have other side effects. </span>Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member.</dd>
<dt>•</dt>
<dd>
<span class="Bold">Antidepressant medicines can interact with other medicines. </span>Know all of the medicines that you or your family member takes. Keep a list of all medicines to show the healthcare provider. Do not start new medicines without first checking with your healthcare provider.</dd>
<dt>•</dt>
<dd>
<span class="Bold">Not all antidepressant medicines prescribed for children are FDA approved for use in children. </span>Talk to your child's healthcare provider for more information.</dd>
</dl>
<p>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p>
<p>This Medication Guide has been approved by the U.S. Food and Drug Administration.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_a44eeb76-2398-4629-833c-8b25c8e2de74"></a><a name="section-16"></a><p></p>
<p class="First">Revised: July 2014<br>71009-0714-8</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_3f688683-a774-46dd-b21a-36bcd3a6ec40"></a><a name="section-17"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label</h1>
<p class="First"><span class="Bold">GSMS</span></p>
<p><span class="Bold">NDC 60429-287-01</span></p>
<p><span class="Bold">100 Capsules</span></p>
<p><span class="Bold">ClomiPRAMINE</span><br><span class="Bold">Hydrochloride</span><br><span class="Bold">Capsules USP</span></p>
<p><span class="Bold">25 mg</span></p>
<p><span class="Bold">Dispense the accompanying</span><br><span class="Bold">medication guide to each patient.</span></p>
<p><span class="Bold">Rx only</span></p>
<div class="Figure">
<a name="id23475608"></a><img alt="Label Graphic-25mg 100s" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4c32971e-feb3-4388-9cd6-d1f99f258b0d&amp;name=clomipramine-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_53e59988-4e95-49ff-935d-701be346e2ac"></a><a name="section-18"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 75mg Capsule Bottle Label</h1>
<p class="First"><span class="Bold">GSMS</span></p>
<p><span class="Bold">NDC 60429-288-01</span></p>
<p><span class="Bold">100 Capsules</span></p>
<p><span class="Bold">ClomiPRAMINE</span><br><span class="Bold">Hydrochloride</span><br><span class="Bold">Capsules USP</span></p>
<p><span class="Bold">75 mg</span></p>
<p><span class="Bold">Dispense the accompanying</span><br><span class="Bold">medication guide to each patient.</span></p>
<p><span class="Bold">Rx only</span></p>
<div class="Figure">
<a name="id23475853"></a><img alt="Label Graphic-50mg 100s" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4c32971e-feb3-4388-9cd6-d1f99f258b0d&amp;name=clomipramine-04-01.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CLOMIPRAMINE HYDROCHLORIDE 		
					</strong><br><span class="contentTableReg">clomipramine hydrochloride capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:60429-287(NDC:51672-4011)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Clomipramine Hydrochloride</strong> (Clomipramine) </td>
<td class="formItem">Clomipramine Hydrochloride</td>
<td class="formItem">25 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Gelatin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Magnesium Stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Titanium Dioxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FERROSOFERRIC OXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C RED NO. 3</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FD&amp;C BLUE NO. 2</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">blue (Dark blue/light blue) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">18mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">CLOM25</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:60429-287-30</td>
<td class="formItem">30  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:60429-287-90</td>
<td class="formItem">90  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:60429-287-01</td>
<td class="formItem">100  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA074694</td>
<td class="formItem">12/31/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CLOMIPRAMINE HYDROCHLORIDE 		
					</strong><br><span class="contentTableReg">clomipramine hydrochloride capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:60429-288(NDC:51672-4013)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Clomipramine Hydrochloride</strong> (Clomipramine) </td>
<td class="formItem">Clomipramine Hydrochloride</td>
<td class="formItem">75 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Gelatin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Magnesium Stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Titanium Dioxide</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">white (opaque) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">20mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">CLOM75</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:60429-288-30</td>
<td class="formItem">30  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:60429-288-90</td>
<td class="formItem">90  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:60429-288-01</td>
<td class="formItem">100  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA074694</td>
<td class="formItem">12/31/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Golden State Medical Supply, Inc.
							(603184490)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Golden State Medical Supply, Inc.</td>
<td class="formItem"></td>
<td class="formItem">603184490</td>
<td class="formItem">REPACK(60429-287, 60429-288)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>53e32533-999c-4912-8671-20e489198ad3</div>
<div>Set id: 4c32971e-feb3-4388-9cd6-d1f99f258b0d</div>
<div>Version: 3</div>
<div>Effective Time: 20150708</div>
</div>
</div> <div class="DistributorName">Golden State Medical Supply, Inc.</div></p>
</body></html>
